Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126860621 | 12686062 | 1 | I | 20160125 | 20160216 | 20160825 | 20160825 | PER | US-NOVOPROD-483519 | NOVO NORDISK | 71.00 | YR | E | F | Y | 0.00000 | 20160825 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126860621 | 12686062 | 1 | PS | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | 0.6 MG, QD | N | U | ES6S511 | 22341 | .6 | MG | SOLUTION FOR INJECTION | QD | |||
| 126860621 | 12686062 | 2 | SS | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | 1.2 MG, QD | N | U | ES6S511 | 22341 | 1.2 | MG | SOLUTION FOR INJECTION | QD | |||
| 126860621 | 12686062 | 3 | SS | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | 0.6 MG, QD | N | U | ES6S511 | 22341 | .6 | MG | SOLUTION FOR INJECTION | QD | |||
| 126860621 | 12686062 | 4 | C | COREG | CARVEDILOL | 1 | 0 | ||||||||||||
| 126860621 | 12686062 | 5 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 126860621 | 12686062 | 6 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 126860621 | 12686062 | 7 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126860621 | 12686062 | 1 | Type 2 diabetes mellitus |
| 126860621 | 12686062 | 4 | Product used for unknown indication |
| 126860621 | 12686062 | 5 | Product used for unknown indication |
| 126860621 | 12686062 | 6 | Product used for unknown indication |
| 126860621 | 12686062 | 7 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126860621 | 12686062 | Abdominal distension | |
| 126860621 | 12686062 | Blood glucose increased | |
| 126860621 | 12686062 | Constipation | |
| 126860621 | 12686062 | Dyspepsia | |
| 126860621 | 12686062 | Flatulence | |
| 126860621 | 12686062 | Hepatic steatosis | |
| 126860621 | 12686062 | Hepatomegaly |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126860621 | 12686062 | 1 | 2014 | 0 | ||
| 126860621 | 12686062 | 2 | 20160131 | 0 | ||
| 126860621 | 12686062 | 3 | 20160216 | 0 |